ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,522.42
      1.05%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      -2.20%
      Bitcoin
      67,935.94
      3.26%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Halozyme Therapeutics Incorporated (HALO)

      7. Halozyme Therapeutics Incorporated (HALO) Financials

      Halozyme Therapeutics Incorporated

      Halozyme Therapeutics Incorporated (HALO)

      Halo Collective Inc
      56.23
      0.26
      (0.46%)
      At close: July 26 4:00PM
      Delayed by 15 minutes
      56.23
      0.02
      ( 0.04% )
      After Hours: 5:11PM
      Delayed by 15 minutes

      Halozyme Therapeutics Incorporated Financial Summary

      The current HALO market cap is 7.16B. The company's latest EPS is USD 2.2125 and P/E is 25.41.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 162.14M221.04M216.03M230.04M195.88M
      Operating Income 53.8M94.46M88.28M101.04M95.54M
      Net Income 39.62M74.75M81.84M85.39M76.82M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 195.99M267.59M443.31M660.12M829.25M
      Operating Income -67.61M144.26M275.9M267.53M337.57M
      Net Income -72.24M129.09M402.71M202.13M281.59M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.7B1.81B1.89B1.73B1.84B
      Total Liabilities 1.63B1.66B1.64B1.65B1.66B
      Total Equity 65.85M151.03M249.18M83.81M177.81M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 565.87M579.92M1.1B1.84B1.73B
      Total Liabilities 474.11M428.88M907.48M1.67B1.65B
      Total Equity 91.77M151.05M196.95M169.8M83.81M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 86.96M153.81M286.22M388.57M129.43M
      Investing -60.16M-5.17M-88.62M-96.91M-82.68M
      Financing -164.61M-162.17M-158.07M-407.99M-489k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -85.42M55.45M299.44M240.11M388.57M
      Investing -5.55M78.35M-406.29M-487.01M-96.91M
      Financing 153.22M-106.28M77.87M362.37M-407.99M

      Stats and Ratios

      Market Cap 7.16B
      Price to Earnings Ratio 25.41
      Price to Sales Ratio 8.63
      Price to Cash Ratio 60.44
      Price to Book Ratio 85.36
      Dividend Yield -

      Share Statistics

      Shares Outstanding 127.27M
      Average Volume (1 week) 958.97k
      Average Volume (1 Month) 1.29M
      52 Week Change 31.38%
      52 Week High 57.085
      52 Week Low 32.83
      Spread (Intraday) 0.71 (1.25%)

      Company Info

      Company Name Halozyme Therapeutics Incorporated
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.halozyme.com
      Industry biological pds,ex diagnstics (2836)